Collection of papers and cards written to Sarah Gilbert

Sarah Gilbert has been studying viruses and vaccines as ways to prevent them for her entire scientific career. Building on her years of experience, Professor Gilbert was able to quickly put that knowledge to use becoming the co-developer and Project Lead for Oxford’s COVID-19 vaccine.

Once the genetic code of COVID-19 was released on 12 January 2020, scientists including Sarah Gilbert, Professor Vaccinology, at the University of Oxford, immediately set to work, on designing a vaccine. On the 6th of March 2020, the Production Team started small-scale manufacture of the Oxford team’s vaccine known as ChAdOx1 nCoV-19. After several stages of cell growth, harvesting and purification the first vials were filled on 2nd April 2020. After rigorous checks, the first volunteers were injected with the vaccine on 23 April 2020. On 30 April 2020, Oxford University signed a deal with pharmaceutical company AstraZeneca to mass-produce the vaccine. This included a clause that no profit would be made from providing the vaccine to low-income countries. Large scale clinical trials followed before the vaccine was approved by the Medicines and Healthcare products Regulatory Agency (MHRA) on 30th December 2020. 5 days later, Brian Pinker was the first person to receive a dose of the Oxford/AstraZeneca vaccine. Over 3 billion doses have been delivered worldwide.

In 2021, Professor Gilbert was awarded an DBE for services to Science and Public Health, and was honoured alongside many of her colleagues. Her book ‘Vaxxers: The Inside Story of the Oxford AstraZeneca Vaccine and the Race Against the Virus’, details her work and those of the team around her.

Thanking Sarah for her appearances at the Science and Technology Select Committee and filled with hope for continued research results, Katherine Fletcher wrote this letter to Sarah Gilbert during the development of Oxford's COVID-19 vaccine.

Sarah Gilbert has been studying viruses and vaccines as ways to prevent them for her entire scientific career. Building on her years of experience, Professor Gilbert was able to quickly put that knowledge to use becoming the co-developer and Project Lead for Oxford’s COVID-19 vaccine.

Once the genetic code of COVID-19 was released on 12 January 2020, scientists including Sarah Gilbert, Professor Vaccinology, at the University of Oxford, immediately set to work, on designing a vaccine. On the 6th of March 2020, the Production Team started small-scale manufacture of the Oxford team’s vaccine known as ChAdOx1 nCoV-19. After several stages of cell growth, harvesting and purification the first vials were filled on 2nd April 2020. After rigorous checks, the first volunteers were injected with the vaccine on 23 April 2020. On 30 April 2020, Oxford University signed a deal with pharmaceutical company AstraZeneca to mass-produce the vaccine. This included a clause that no profit would be made from providing the vaccine to low-income countries. Large scale clinical trials followed before the vaccine was approved by the Medicines and Healthcare products Regulatory Agency (MHRA) on 30th December 2020. 5 days later, Brian Pinker was the first person to receive a dose of the Oxford/AstraZeneca vaccine. Over 3 billion doses have been delivered worldwide.

In 2021, Professor Gilbert was awarded an DBE for services to Science and Public Health, and was honoured alongside many of her colleagues. Her book ‘Vaxxers: The Inside Story of the Oxford AstraZeneca Vaccine and the Race Against the Virus’, details her work and those of the team around her.

Sarah Gilbert has been studying viruses and vaccines as ways to prevent them for her entire scientific career. Building on her years of experience, Professor Gilbert was able to quickly put that knowledge to use becoming the co-developer and Project Lead for Oxford’s COVID-19 vaccine.

Once the genetic code of COVID-19 was released on 12 January 2020, scientists including Sarah Gilbert, Professor Vaccinology, at the University of Oxford, immediately set to work, on designing a vaccine. On the 6th of March 2020, the Production Team started small-scale manufacture of the Oxford team’s vaccine known as ChAdOx1 nCoV-19. After several stages of cell growth, harvesting and purification the first vials were filled on 2nd April 2020. After rigorous checks, the first volunteers were injected with the vaccine on 23 April 2020. On 30 April 2020, Oxford University signed a deal with pharmaceutical company AstraZeneca to mass-produce the vaccine. This included a clause that no profit would be made from providing the vaccine to low-income countries. Large scale clinical trials followed before the vaccine was approved by the Medicines and Healthcare products Regulatory Agency (MHRA) on 30th December 2020. 5 days later, Brian Pinker was the first person to receive a dose of the Oxford/AstraZeneca vaccine. Over 3 billion doses have been delivered worldwide.

In 2021, Professor Gilbert was awarded an DBE for services to Science and Public Health, and was honoured alongside many of her colleagues. Sarah joined a list of 21 Honorary Fellows of the Royal Academy of Arts, individuals outside of the art world who are nominated for their contributions to their field.

Over 3 billion doses of the Oxford/AstraZeneca COVID-19 vaccine have been delivered worldwide. Some of those that received them wrote to Professor Gilbert to say thank you. After months of worry about catching the virus, the writer recounts her husband's mild COVID-19 infection after his vaccination, which they only identified following a lateral flow test. The letter ends with "I thought this real life example of how our lives have been made safer may cheer you a little at this Christmas time."

Sarah Gilbert has been studying viruses and vaccines as ways to prevent them for her entire scientific career. Building on her years of experience, Professor Gilbert was able to quickly put that knowledge to use becoming the co-developer and Project Lead for Oxford’s COVID-19 vaccine.

Once the genetic code of COVID-19 was released on 12 January 2020, scientists including Sarah Gilbert, Professor Vaccinology, at the University of Oxford, immediately set to work, on designing a vaccine. On the 6th of March 2020, the Production Team started small-scale manufacture of the Oxford team’s vaccine known as ChAdOx1 nCoV-19. After several stages of cell growth, harvesting and purification the first vials were filled on 2nd April 2020. After rigorous checks, the first volunteers were injected with the vaccine on 23 April 2020. On 30 April 2020, Oxford University signed a deal with pharmaceutical company AstraZeneca to mass-produce the vaccine. This included a clause that no profit would be made from providing the vaccine to low-income countries. Large scale clinical trials followed before the vaccine was approved by the Medicines and Healthcare products Regulatory Agency (MHRA) on 30th December 2020. 5 days later, Brian Pinker was the first person to receive a dose of the Oxford/AstraZeneca vaccine.

In 2021, Professor Gilbert was awarded an DBE for services to Science and Public Health, and was honoured alongside many of her colleagues. Her book ‘Vaxxers: The Inside Story of the Oxford AstraZeneca Vaccine and the Race Against the Virus’, details her work and those of the team around her.

Over 3 billion doses of the Oxford/AstraZeneca COVID-19 vaccine have been delivered worldwide. Some of those that received them wrote to Professor Gilbert to say thank you. This writer says "This vaccine has played a vital role in getting our huge population in india vaccinated and hopefully we shall now be in a better position to face future uncertainties arising due to the pandemic."

Sarah Gilbert has been studying viruses and vaccines as ways to prevent them for her entire scientific career. Building on her years of experience, Professor Gilbert was able to quickly put that knowledge to use becoming the co-developer and Project Lead for Oxford’s COVID-19 vaccine.

Once the genetic code of COVID-19 was released on 12 January 2020, scientists including Sarah Gilbert, Professor Vaccinology, at the University of Oxford, immediately set to work, on designing a vaccine. On the 6th of March 2020, the Production Team started small-scale manufacture of the Oxford team’s vaccine known as ChAdOx1 nCoV-19. After several stages of cell growth, harvesting and purification the first vials were filled on 2nd April 2020. After rigorous checks, the first volunteers were injected with the vaccine on 23 April 2020. On 30 April 2020, Oxford University signed a deal with pharmaceutical company AstraZeneca to mass-produce the vaccine. This included a clause that no profit would be made from providing the vaccine to low-income countries. Large scale clinical trials followed before the vaccine was approved by the Medicines and Healthcare products Regulatory Agency (MHRA) on 30th December 2020. 5 days later, Brian Pinker was the first person to receive a dose of the Oxford/AstraZeneca vaccine.

In 2021, Professor Gilbert was awarded an DBE for services to Science and Public Health, and was honoured alongside many of her colleagues. Her book ‘Vaxxers: The Inside Story of the Oxford AstraZeneca Vaccine and the Race Against the Virus’, details her work and those of the team around her.

Over 3 billion doses of the Oxford/AstraZeneca COVID-19 vaccine have been delivered worldwide. Some of those that received them wrote to Professor Gilbert to say thank you. This writer said "I walked out of the vaccination centre and sent you thanks with tears in my eyes."

Sarah Gilbert has been studying viruses and vaccines as ways to prevent them for her entire scientific career. Building on her years of experience, Professor Gilbert was able to quickly put that knowledge to use becoming the co-developer and Project Lead for Oxford’s COVID-19 vaccine.

Once the genetic code of COVID-19 was released on 12 January 2020, scientists including Sarah Gilbert, Professor Vaccinology, at the University of Oxford, immediately set to work, on designing a vaccine. On the 6th of March 2020, the Production Team started small-scale manufacture of the Oxford team’s vaccine known as ChAdOx1 nCoV-19. After several stages of cell growth, harvesting and purification the first vials were filled on 2nd April 2020. After rigorous checks, the first volunteers were injected with the vaccine on 23 April 2020. On 30 April 2020, Oxford University signed a deal with pharmaceutical company AstraZeneca to mass-produce the vaccine. This included a clause that no profit would be made from providing the vaccine to low-income countries. Large scale clinical trials followed before the vaccine was approved by the Medicines and Healthcare products Regulatory Agency (MHRA) on 30th December 2020. 5 days later, Brian Pinker was the first person to receive a dose of the Oxford/AstraZeneca vaccine.

In 2021, Professor Gilbert was awarded an DBE for services to Science and Public Health, and was honoured alongside many of her colleagues. Her book ‘Vaxxers: The Inside Story of the Oxford AstraZeneca Vaccine and the Race Against the Virus’, details her work and those of the team around her.

Over 3 billion doses of the Oxford/AstraZeneca COVID-19 vaccine have been delivered worldwide. Some of those that received them wrote to Professor Gilbert to say thank you: "This card is also to send our thanks to you, your team and colleagues for all your hard work and dedivation in the development of the COVID vaccine."

Sarah Gilbert has been studying viruses and vaccines as ways to prevent them for her entire scientific career. Building on her years of experience, Professor Gilbert was able to quickly put that knowledge to use becoming the co-developer and Project Lead for Oxford’s COVID-19 vaccine.

Once the genetic code of COVID-19 was released on 12 January 2020, scientists including Sarah Gilbert, Professor Vaccinology, at the University of Oxford, immediately set to work, on designing a vaccine. On the 6th of March 2020, the Production Team started small-scale manufacture of the Oxford team’s vaccine known as ChAdOx1 nCoV-19. After several stages of cell growth, harvesting and purification the first vials were filled on 2nd April 2020. After rigorous checks, the first volunteers were injected with the vaccine on 23 April 2020. On 30 April 2020, Oxford University signed a deal with pharmaceutical company AstraZeneca to mass-produce the vaccine. This included a clause that no profit would be made from providing the vaccine to low-income countries. Large scale clinical trials followed before the vaccine was approved by the Medicines and Healthcare products Regulatory Agency (MHRA) on 30th December 2020. 5 days later, Brian Pinker was the first person to receive a dose of the Oxford/AstraZeneca vaccine.

In 2021, Professor Gilbert was awarded an DBE for services to Science and Public Health, and was honoured alongside many of her colleagues. Her book ‘Vaxxers: The Inside Story of the Oxford AstraZeneca Vaccine and the Race Against the Virus’, details her work and those of the team around her.

Over 3 billion doses of the Oxford/AstraZeneca COVID-19 vaccine have been delivered worldwide. Some of those that received them wrote to Professor Gilbert to say thank you: "Since I received my fist vaccine back in march and as normal life has gradullay resumed, I think about you and the Oxford team nearly every day and feel profoundly graeful."

Sarah Gilbert has been studying viruses and vaccines as ways to prevent them for her entire scientific career. Building on her years of experience, Professor Gilbert was able to quickly put that knowledge to use becoming the co-developer and Project Lead for Oxford’s COVID-19 vaccine.

Once the genetic code of COVID-19 was released on 12 January 2020, scientists including Sarah Gilbert, Professor Vaccinology, at the University of Oxford, immediately set to work, on designing a vaccine. On the 6th of March 2020, the Production Team started small-scale manufacture of the Oxford team’s vaccine known as ChAdOx1 nCoV-19. After several stages of cell growth, harvesting and purification the first vials were filled on 2nd April 2020. After rigorous checks, the first volunteers were injected with the vaccine on 23 April 2020. On 30 April 2020, Oxford University signed a deal with pharmaceutical company AstraZeneca to mass-produce the vaccine. This included a clause that no profit would be made from providing the vaccine to low-income countries. Large scale clinical trials followed before the vaccine was approved by the Medicines and Healthcare products Regulatory Agency (MHRA) on 30th December 2020. 5 days later, Brian Pinker was the first person to receive a dose of the Oxford/AstraZeneca vaccine.

In 2021, Professor Gilbert was awarded an DBE for services to Science and Public Health, and was honoured alongside many of her colleagues. Her book ‘Vaxxers: The Inside Story of the Oxford AstraZeneca Vaccine and the Race Against the Virus’, details her work and those of the team around her.

Over 3 billion doses of the Oxford/AstraZeneca COVID-19 vaccine have been delivered worldwide. Some of those that received them wrote to Professor Gilbert to say thank you. Following a psoitive COVID test, this letter writer was unwell but "I was saved from serious disease (and hopefully any longer-term COVID illness by your vaccine." They were able to return to work and family life and credit "the power of hope and faith in your vaccine helped enormously to keep plodding though those days."

Sarah Gilbert has been studying viruses and vaccines as ways to prevent them for her entire scientific career. Building on her years of experience, Professor Gilbert was able to quickly put that knowledge to use becoming the co-developer and Project Lead for Oxford’s COVID-19 vaccine.

Once the genetic code of COVID-19 was released on 12 January 2020, scientists including Sarah Gilbert, Professor Vaccinology, at the University of Oxford, immediately set to work, on designing a vaccine. On the 6th of March 2020, the Production Team started small-scale manufacture of the Oxford team’s vaccine known as ChAdOx1 nCoV-19. After several stages of cell growth, harvesting and purification the first vials were filled on 2nd April 2020. After rigorous checks, the first volunteers were injected with the vaccine on 23 April 2020. On 30 April 2020, Oxford University signed a deal with pharmaceutical company AstraZeneca to mass-produce the vaccine. This included a clause that no profit would be made from providing the vaccine to low-income countries. Large scale clinical trials followed before the vaccine was approved by the Medicines and Healthcare products Regulatory Agency (MHRA) on 30th December 2020. 5 days later, Brian Pinker was the first person to receive a dose of the Oxford/AstraZeneca vaccine.

In 2021, Professor Gilbert was awarded an DBE for services to Science and Public Health, and was honoured alongside many of her colleagues. Her book ‘Vaxxers: The Inside Story of the Oxford AstraZeneca Vaccine and the Race Against the Virus’, details her work and those of the team around her.